PRACTICES

The competition in the healthcare and life sciences industries is intensifying on a global scale, making it challenging even for major players to pursue R&D, manufacturing, and marketing on their own. Regulatory compliance and contractual and IP-related disputes also present major business risks.

TKI has extensive experience in this sector, having advised pharmaceutical, medical device and biotechnology companies on a full range of matters, spanning (inbound and outbound) investments and acquisitions, joint ventures, licensing, distribution and joint research arrangements, strategies to address and mitigate the risk of regulatory non-compliances and disputes.